George F. Vande Woude
George F. Vande Woude
Verified email at
Cited by
Cited by
Met, metastasis, motility and more
C Birchmeier, W Birchmeier, E Gherardi, GFV Woude
Nature reviews Molecular cell biology 4 (12), 915-925, 2003
Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor
NS Duesbery, CP Webb, SH Leppla, VM Gordon, KR Klimpel, ...
Science 280 (5364), 734-737, 1998
Molecular cloning of a new transforming gene from a chemically transformed human cell line
CS Cooper, M Park, DG Blair, MA Tainsky, K Huebner, CM Croce, ...
Nature 311 (5981), 29-33, 1984
Abnormal centrosome amplification in the absence of p53
K Fukasawa, T Choi, R Kuriyama, S Rulong, GFV Woude
Science 271 (5256), 1744-1747, 1996
The c-mos proto-oncogene product is a cytostatic factor responsible for meiotic arrest in vertebrate eggs
N Sagata, N Watanabe, GFV Woude, Y Ikawa
Nature 342 (6249), 512-518, 1989
Function of c-mos proto-oncogene product in meiotic maturation in Xenopus oocytes
N Sagata, M Oskarsson, T Copeland, J Brumbaugh, GFV Woude
Nature 335 (6190), 519-525, 1988
Mechanism of met oncogene activation
M Park, M Dean, CS Cooper, M Schmidt, SJ O'Brien, DG Blair, ...
Cell 45 (6), 895-904, 1986
Novel therapeutic inhibitors of the c-Met signaling pathway in cancer
JP Eder, GFV Woude, SA Boerner, PM LoRusso
Clinical Cancer Research 15 (7), 2207-2214, 2009
Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner
M Fiscella, HL Zhang, S Fan, K Sakaguchi, S Shen, WE Mercer, ...
Proceedings of the National Academy of Sciences 94 (12), 6048-6053, 1997
A cytoskeletal structure with associated polyribosomes obtained from HeLa cells
R Lenk, L Ransom, Y Kaufmann, S Penman
Cell 10 (1), 67-78, 1977
Met receptor tyrosine kinase: enhanced signaling through adapter proteins
KA Furge, YW Zhang, GFV Woude
Oncogene 19 (49), 5582-5589, 2000
Activating mutations for the met tyrosine kinase receptor in human cancer
M Jeffers, L Schmidt, N Nakaigawa, CP Webb, G Weirich, T Kishida, ...
Proceedings of the National Academy of Sciences 94 (21), 11445-11450, 1997
Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways
GH Xiao, M Jeffers, A Bellacosa, Y Mitsuuchi, GFV Woude, JR Testa
Proceedings of the National Academy of Sciences 98 (1), 247-252, 2001
Met and hepatocyte growth factor/scatter factor expression in human gliomas
S Koochekpour, M Jeffers, S Rulong, G Taylor, E Klineberg, EA Hudson, ...
Cancer research 57 (23), 5391-5398, 1997
A novel germ line juxtamembrane Met mutation in human gastric cancer
JH Lee, SU Han, H Cho, B Jennings, B Gerrard, M Dean, L Schmidt, ...
Oncogene 19 (43), 4947-4953, 2000
Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation
YW Zhang, Y Su, OV Volpert, GFV Woude
Proceedings of the National Academy of Sciences 100 (22), 12718-12723, 2003
Inactivation of LRG-47 and IRG-47 reveals a family of interferon γ–inducible genes with essential, pathogen-specific roles in resistance to infection
CM Collazo, GS Yap, GD Sempowski, KC Lusby, L Tessarollo, ...
The Journal of experimental medicine 194 (2), 181-188, 2001
HGF/SF‐met signaling in the control of branching morphogenesis and invasion
YW Zhang, GF Vande Woude
Journal of cellular biochemistry 88 (2), 408-417, 2003
The human met oncogene is related to the tyrosine kinase oncogenes
M Dean, M Park, MM Le Beau, TS Robins, MO Diaz, JD Rowley, DG Blair, ...
Nature 318 (6044), 385-388, 1985
Hepatocyte growth factor/scatter factor—Met signaling in tumorigenicity and invasion/metastasis
M Jeffers, S Rong, GFV Woude
Journal of Molecular Medicine 74 (9), 505-513, 1996
The system can't perform the operation now. Try again later.
Articles 1–20